Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Ankam, Inc.Ankam, Inc. Reports Revenue Growth to $325,000 Despite Net Loss in Latest 10-K Filing
INTELLIGENT PROTECTION MANAGEMENT CORP.Intelligent Protection Management Corp. Reports 2,050% Revenue Growth to $23.6 Million for Fiscal Year 2025
lululemon athletica inc.Lululemon Reports $11.1 Billion Revenue for Fiscal Year 2026, Driven by International Growth
Fold Holdings, Inc.Fold Holdings Reports 34% Revenue Growth to $31.8 Million for 2025
Oklo Inc.Oklo Inc. Reports $105.7 Million Net Loss and Significant Expense Increases in 2025
Trio Petroleum Corp.Trio Petroleum Reports 1,029.4% Revenue Increase and Improved Net Loss in Latest 10-Q
Trevi Therapeutics, Inc.Trevi Therapeutics Reports $42.8 Million Net Loss for 2025, Plans Phase 3 Trials
IZEA Worldwide, Inc.IZEA Worldwide Reports $31.2 Million Revenue for Fiscal Year 2025, Net Income Improves
SafeSpace Global CorpSafeSpace Global Corporation Reports Improved Net Loss of $1.12 Million for Quarter Ending January 31, 2026
NEXTNAV INC.NextNav Inc. Reports $189.3 Million Net Loss and 19% Revenue Decline for Fiscal Year 2025
HEALTHEQUITY, INC.HealthEquity Reports $1.31 Billion Revenue and 123% Net Income Increase for Fiscal Year Ending January 31, 2026
BlackSky Technology Inc.BlackSky Technology Inc. Reports $106.6 Million Revenue for Fiscal Year 2025
Gossamer Bio, Inc.Gossamer Bio Reports 58% Revenue Decline and $170.4 Million Net Loss for Fiscal Year 2025
AN2 Therapeutics, Inc.AN2 Therapeutics Reports $35.2 Million Net Loss for 2025, Advances Product Pipeline
Academy Sports & Outdoors, Inc.Academy Sports + Outdoors Reports $120 Million Net Sales Increase for Fiscal Year Ending January 31, 2026
Kalaris Therapeutics, Inc.Kalaris Therapeutics Reports Annual Financial Results for 2025
Longeveron Inc.Longeveron Inc. Reports $1.2 Million Revenue Decline and $22.7 Million Net Loss in Annual Filing
PharmaCyte Biotech, Inc.PharmaCyte Biotech Reports $1.6 Million Net Loss for Third Quarter, Focuses on Cancer Therapy Development
WEWARDS, INC.Wewards, Inc. Reports No Revenue and Increased Losses for Three and Nine Months Ended February 28, 2026
NOBILITY HOMES INCNobility Homes Reports Decline in Q1 Fiscal 2026 Financial Performance
Idaho Copper CorpIdaho Copper Corporation Reports $3.1 Million Net Loss, Focuses on CuMo Project Development
NAPC Defense, Inc.NAPC Defense Reports No Revenue and Increased Losses in Latest Financial Filing
GAP INCGap Inc. Reports 2% Increase in Net Sales to $15.4 Billion for Fiscal 2025
GEORGE RISK INDUSTRIES, INC.George Risk Industries Reports 15.21% Revenue Growth in Third Quarter
Rise Gold Corp.Rise Gold Corp. Reports Increased Net Loss and Improved Financial Position in Latest 10-Q Filing